A61K 40/46
Viral antigens
A61K40/46 (Viral antigens) appears on 793 US grants and 1,591 published applications in this corpus.
Search patents in A61K- Granted patents
- 793
- Published applications
- 1,591
- Assignees
- 728
- Inventors
- 2,588
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 7 | 0 |
| 2000 | 7 | 0 |
| 2001 | 8 | 7 |
| 2002 | 13 | 33 |
| 2003 | 18 | 43 |
| 2004 | 18 | 63 |
| 2005 | 9 | 37 |
| 2006 | 20 | 38 |
| 2007 | 12 | 22 |
| 2008 | 15 | 29 |
| 2009 | 7 | 32 |
| 2010 | 24 | 47 |
| 2011 | 18 | 41 |
| 2012 | 16 | 41 |
| 2013 | 28 | 41 |
| 2014 | 27 | 54 |
| 2015 | 37 | 50 |
| 2016 | 33 | 44 |
| 2017 | 31 | 66 |
| 2018 | 41 | 76 |
| 2019 | 31 | 98 |
| 2020 | 38 | 86 |
| 2021 | 50 | 132 |
| 2022 | 41 | 112 |
| 2023 | 61 | 139 |
| 2024 | 53 | 124 |
| 2025 | 61 | 77 |
| 2026 | 49 | 59 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Dual CAR expressing T cells individually linked to CD28 and 4-1BB6 Oct 2026US 12,753,218 B2The Trustees of the University of Pennsylvania
- Methods of isolating T cells and T-cell receptors from peripheral blood by single-cell analysis for immunotherapy6 Oct 2026US 12,753,437 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Modulation of expression of genes related to T cell exhaustion29 Sep 2026US 12,747,431 B2The Trustees of the University of Pennsylvania
- Histone deacetylase inhibitors for use in immunotherapy22 Sep 2026US 12,740,986 B2Viracta Subsidiary, Inc.
- Tumor cell-derived exosomes and method of treating colorectal cancer8 Sep 2026US 12,728,156 B2Regents of the University of Minnesota
- Influenza estem immunogens8 Oct 2026US 2026/0306612 A1
- Chimeric engulfment receptor molecules and methods of use8 Oct 2026US 2026/0308281 A1Cero Therapeutics Holdings, Inc.
- Chemoenzymatic method for the detection of cell-cell proximity interaction and isolation of tumor-specific antigen reactive t cells for immune therapy8 Oct 2026US 2026/0308537 A1The Scripps Research Institute
- Populations of enriched regulatory t cells and methods for producing same1 Oct 2026US 2026/0297523 A1Cellenkos, Inc.
- Hdac inhibitors for use with nk cell based therapies24 Sep 2026US 2026/0284060 A9NantKwest, Inc.
Most cited
By later US patents
- Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells512US 6,352,694 B1Genetics Institute, Inc. · 2002
- Methods for selectively stimulating proliferation of T cells452US 6,534,055 B1Genetics Institute, Inc. · 2003
- Methods of treating HIV infected subjects386US 6,905,680 B2Genetics Institute, Inc. · 2005
- Methods for selectively stimulating proliferation of T cells385US 6,887,466 B2Genetics Institute, Inc. · 2005
- Methods for selectively stimulating proliferation of T cells384US 6,905,681 B1Genetics Institute, Inc. · 2005